Achyrocline B (3,5 dihydroxy-6,7,8-trimethoxyflavone) synergizes with 5-fluorouracil allowing for dose reduction and reduced off-target toxicity in the treatment of colonic and pancreatic cancers-Reference-Cited by-同舟云学术

Achyrocline B (3,5 dihydroxy-6,7,8-trimethoxyflavone) synergizes with 5-fluorouracil allowing for dose reduction and reduced off-target toxicity in the treatment of colonic and pancreatic cancers

Published:2023-11 Issue: Volume:167 Page:115546
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Cartwright Brian M.,Corso Jaclyn N.,Lightner Janet,Whitted Crystal,Torrenegra Ruben D.,Krishnan Koyamangalath,Palau Victoria E.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. N.A. Howlader N, Krapcho M., et al. (eds), SEER Cancer Statistics Review, 1975–2016, National Cancer Institute, Bethesda, MD, 2019.

2. Colon Cancer Treatment (PDQ®): health professional version, PDQ cancer information summaries, national cancer institute (US);P.D.Q.A.T.E. Board;Bethesda (MD,2023

3. PDQ®): Health Professional Version, PDQ cancer information summaries, national cancer institute (US), Bethesda (MD);P.D.Q.A.T.E. Board;Pancreat. Cancer Treat. (Adult),2023

4. New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids;Rodrigues;Arch. Toxicol.,2021

5. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases;Cordier;Cancer Chemother. Pharmacol.,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery;Frontiers in Oncology;2024-03-05